Avicella Capital
Overview
Avicella Capital is a venture capital firm that seeks to invest in the therapeutics, medical devices, diagnostics, and health tech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Faeth Therapeutics, Inc. | Oct 2025 | VC Round | Co-investor |
| Convergence Medical Robotics | Jan 2025 | Series A | Lead |
| Kinoxis Therapeutics | Aug 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Avicella Capital based?
Avicella Capital is headquartered in Seattle, Washington, United States.
When was Avicella Capital founded?
Avicella Capital was founded in 2024.
How many portfolio companies does Avicella Capital have?
Avicella Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Avicella Capital's portfolio?
Portfolio companies visible on Caplight include Faeth Therapeutics, Inc., Convergence Medical Robotics, Kinoxis Therapeutics.
What was Avicella Capital's most recent investment shown here?
Avicella Capital's most recent investment in this portfolio sample was in Faeth Therapeutics, Inc. in 2025.
What sectors does Avicella Capital focus on?
Avicella Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Avicella Capital focus on?
Stage focus information for Avicella Capital is not publicly available.